Description

Dofamin (Dopamine Hydrochloride) Concentrate for Infusions 40 mg/ml. 5 ml. Ampoules №10

Ingredients:

Each 5 ml ampoule contains 200 mg of dopamine hydrochloride as the active ingredient.

Dosage:

The dosage and rate of administration should be adjusted according to the patient’s condition and response to treatment. It is typically administered intravenously. Consult a healthcare professional for the appropriate dosage.

Indications:

Dofamin is indicated for the treatment of shock, heart failure, and other conditions where a positive inotropic effect is needed. It helps improve cardiac function and increase blood pressure.

Contraindications:

Do not use Dofamin in patients with pheochromocytoma, ventricular fibrillation, or hypersensitivity to dopamine. It should be used with caution in patients with arrhythmias or hypertension.

Directions:

Administer Dofamin under the supervision of a healthcare provider experienced in the use of vasopressor agents. Monitor the patient’s blood pressure and cardiac function closely during administration.

Scientific Evidence:

Dopamine, the active ingredient in Dofamin, acts on adrenergic and dopaminergic receptors in the body. It increases myocardial contractility and heart rate, leading to improved cardiac output. Studies have shown that dopamine infusion can be beneficial in patients with cardiogenic shock (Source: Journal of the American College of Cardiology).

Additional Information:

• Storage: Store Dofamin at controlled room temperature away from light and moisture.
• Side Effects: Common side effects may include tachycardia, arrhythmias, and hypertension.

Dofamin is a vital medication used in critical care settings to support hemodynamic stability in patients with various cardiovascular conditions. Its pharmacological action on the cardiovascular system makes it a cornerstone in the management of shock and heart failure.

Clinical trials have demonstrated the efficacy of dopamine in improving hemodynamics and organ perfusion in patients with severe heart failure. The drug’s ability to enhance cardiac output and peripheral perfusion has been well-documented, making it a valuable tool in the armamentarium of healthcare providers managing critically ill patients.